Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H11ClN2O2S |
Molecular Weight | 294.757 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(CC2C(=O)N=C3SCCN3C2=O)C=C1
InChI
InChIKey=QSKVYHYMQQQAFS-UHFFFAOYSA-N
InChI=1S/C13H11ClN2O2S/c14-9-3-1-8(2-4-9)7-10-11(17)15-13-16(12(10)18)5-6-19-13/h1-4,10H,5-7H2
Nuclomedone (TEI-3096), a thiazolopyrimidine compound has been shown to suppress adjuvant arthritis in rats without any effect on conventional inflammation. TEI-3096 also enhanced the delayed type hypersensitivity in mice and rats. These results suggests that TEI-3096 restores the abnormal immune response. Nuclomedone was discovered by Teijin and investigated as a potential treatment for rheumatoid arthritis and inflammatory disorders.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Immunopharmacological profile of TEI-3096: a new immunomodulator. | 1982-1983 |
|
Inhibitory effect of TI-31 on autoimmune nephritis in NZB/NZW F1 mice through regulation of the immune response. | 1987 Apr |
|
Anti-arthritic and immunoregulatory effects of TI-31 on collagen-induced arthritis. | 1987 Nov |
|
Characterization of immunomodulating action of TI-31 on antibody response in mice. | 1991 Aug |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3437603
Oral Nuclomedone (TI-31) treatment in doses of 10 and 50 mg/kg daily for 7 days prior to collagen immunization depressed the development of arthritis in rats.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1837801
Nuclomedone (TI-31), at concentrations of 10 and 100 uM, suppressed the antibody response to T cell-dependent (sheep red blood cells, SRBC) and -independent antigens (trinitrophenyl-lipopolysaccharide, TNP-LPS and TNP-Ficoll).
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
75963-52-9
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
C72930
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
100000083626
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
128798
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
SUB09388MIG
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106465
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
DTXSID2046208
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
MR28U787Z2
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY | |||
|
6122
Created by
admin on Sat Dec 16 15:48:30 GMT 2023 , Edited by admin on Sat Dec 16 15:48:30 GMT 2023
|
PRIMARY |
ACTIVE MOIETY